Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

By Xcenda

While biosimilars have made great strides since the first US launch, there still appears to be room for growth in their uptake.

Download these slides to learn more about how payer decision-making is affecting overall adoption of biosimilars, cost reduction and ultimately impact on patients.

By reading this content, you will learn: 

  • Current biosimilars reimbursement trends
  • Payer perception and treatment of biosimilars in formulary decision making
  • Key considerations for manufacturers to support effective reimbursement and formulary placement
  • What’s on the horizon in the biosimilars space

Enter Your Information to Receive the Slides